Cerence (NASDAQ: CRNC) CFO awarded 131,694 RSUs vesting 2026-2028

Rhea-AI Filing Summary

Cerence Inc. CFO Antonio Rodriquez reported an equity award on a Form 4. On January 9, 2026, he was granted 131,694 shares of Common Stock, reflecting restricted stock units with a reported value of $12.35 per share.

The footnote explains this is a grant of Restricted Stock Units under a Restricted Stock Unit Agreement. The RSUs vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Rodriquez beneficially owned 575,246 shares of Cerence common stock, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodriquez Antonio

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		131,694(1)	A	$12.35	575,246	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Stock Units subject to the Restricted Stock Unit Agreement. Shares vest one-third on each of October 1, 2026, 2027, and 2028.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cerence (CRNC) disclose in this Form 4?

The Form 4 reports that Cerence Inc. CFO Antonio Rodriquez received a grant of 131,694 shares of Common Stock in the form of restricted stock units on January 9, 2026 at a reported value of $12.35 per share.

How do the Cerence (CRNC) CFOs restricted stock units vest?

The filing states the grant is Restricted Stock Units that vest in three equal parts: one-third on each of October 1, 2026, October 1, 2027, and October 1, 2028.

How many Cerence (CRNC) shares does the CFO own after this transaction?

After the reported grant, CFO Antonio Rodriquez beneficially owned 575,246 shares of Cerence common stock, reported as held directly.

What security type is involved in this Cerence (CRNC) Form 4 filing?

The transaction involves Cerence Inc. Common Stock, reported as a grant of restricted stock units that are scheduled to vest over time.

What is the role of the reporting person in this Cerence (CRNC) insider filing?

The reporting person, Antonio Rodriquez, is identified as an officer of Cerence Inc. with the title CFO and is not listed as a director or 10% owner.

Is the Cerence (CRNC) CFOs ownership reported as direct or indirect?

The Form 4 indicates the 575,246 shares beneficially owned following the transaction are held with direct (D) ownership, with no indirect ownership nature specified.